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Summary.-The ascorbyl radical concentration has been observed, by means of
electron spin resonance spectroscopy, in the blood and spleen of female Wistar rats
carrying a Yoshida tumour. The ascorbyl radical concentration of the tumour
tissue itself was studied as the tumour was developing, and as it was regressing after
treatment with methylene dimethane sulphonate. Changes in the concentration of
this radical may be related to host tumour reactions.
SYSTEMATIC STUDIES of the changes in
the radical concentration of tumours
during their development have been
carried out using lyophilized samples
(Saprin et al., 1967a, b; Driscoll et al.,
1967). However, little work appears to
have been done on the changes in the
radical concentration of surviving tissue
during the development of the diseases.
A study of the changes in the ascorbyl
radical concentration of fresh tissue from
mice developing a myeloid leukaemia has
been reported previously (Dodd and Giron-
Conland, 1975). A similar study, in which
the ascorbyl radical concentration of
various tissues of rats bearing a Yoshida
tumour was examined, is reported below.
MATERIALS AND METHODS
The Yoshida tumour is an undifferentiated
tuinour that originated in a pen-bred albino
rat in 1943 (Yoshida, Muta and Sasaki, 1944).
The tumour Mwas transplanted into other pen-
bred albino rats and later into Wistar rats
(Stewart et al., 1959). At this Institute, the
solid tumour has been passaged through
several generations by a s.c. implant of
approximately 01 g of tumour tissue into
the back of the female WNistar rat.
This tumour has a uniform and repro-
ducible growth rate and shows particular
sensitivity to treatment with methylene
dimethane sulphonate (MDMS) (Fox, 1969).
The tumour in 90% of the animals can be
eliminated by a single dose of MDMS in
physiological saline. 0.1 ml of a solution of
5 mg MDMS per ml of saline is injected i.p.
for every 50 g body wt. of the animal.
The tumour tissue itself is macroscopi-
cally heterogeneous. Some parts are red in
colour whilst others are white. Histological
examination showred that the red tissue was
largely composed of cells with intact nuclei,
although scattered areas of cell death and
inflammatory reaction were visible. The red
tissue is referred to in this paper as viable
tissue. Histological examination ofthe white
tissue showed large areas from which all the
tumour cells had disapperared, leaving ghost
cells and infiltrating polymorphonuclear
leucocytes. This tissue also contained small
areas of survivng tumour cells clustered
around the blood vessels. In this paper, the
white tissue is referred to as degenerating
tissue. Both viable and degenerating tissue
Nere examined by ESR. Between layers of
tumour tissue and around the outside of the
tumour, thin " tissue " wAas found. Histo-
logical and electron micrographical exami-
nation of this showred that it contained few
intact cells and some collagen fibres. It was
probably formed as a result of an inflamma-
tory response.
A piece of viable tissue from a 7-day-oldESR OF TUMOUR. I
tumour was implanted on Day 0. When
required, MDMS was administered on Day 7
after implantation.
Muscle tissue was taken from the back of
one rat and cut into pieces weighing approxi-
mately 041 g. These were implanted s.c. into
the backs of control rats, in exactly the same
way as the Yoshida implant.
The rats were of the Wistar outbred
strain, which had been maintained at the
Paterson Laboratories for several years.
Female rats weighing 200-250 g were used.
About 4-5 rats a day were used throughout
the experiments on the muscle implant and
the developing Yoshida tumour, and about
2-3 rats a day were used throughout the
blood, spleen and regressing Yoshida tumour
studies. These rats were starved overnight
prior to sacrifice.
Blood samples were taken whilst the
animals were under ether narcosis, and were
placed in commercially prepared 2-5-ml tubes
containing approximately 6 mg of solid
potassium ethylene diamine tetracetate anti-
coagulant. The tumour, spleen and muscle
implant were removed, placed on Petri dishes
and stored on ice until required. Blood
samples were examined in a Varian aqueous
cell and tissue samples in a tissue cell de-
scribed previously (Dodd and Giron-Conland,
1975). A Varian E-9 spectrometer was used
at the settings stated previously (Dodd and
Giron-Conland, 1975). For the analysis of
spectra of blood and spleen samples, a signal
averager was used in conjunction with the
spectrometer. The models used were a
Nicolet 1070, kindly loaned by the University
of Manchester, Department of Chemistry,
and a model 1020A. The sample spectra
were averaged over 8 scans.
The spectra were quantitated by recording
the relative heights of the ascorbyl radical
signal and a manganese standard signal. A
correction was made for the weight of tissue
examined. This was not necessary in the
case of blood, when a constant volume was
examined.
RESULTS
Blood
The ascorbyl radical concentration of
the blood of rats bearing an implant of
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FIG. 1. Changes in the weight of the Yoshida tumour with time after implantation. developing
tumour; regressing tumour (MDMS on Day 7); vertical lines show the standard error.
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normal muscle was examined for a 13-day
post-implant period. No significant dif-
ference in the ascorbyl radical concen-
tration of the blood of these animals and
those of untreated rats was observed.
Therefore, the mean value obtained for the
relative radical concentration of the blood
of all the rats bearing a muscle implant
was used as the control value in the
experiments examining the blood of the
Yoshida-bearing rats.
The mean ascorbyl radical concen-
tration of the samples taken per day from
rats bearing a developing Yoshida tumour
was not significantly lower than that of all
the controls. However, if the ascorbyl
radical concentration of the blood of all
the examined rats bearing a developing
Yoshida tumour was compared with that
of all the controls, a Mann-Whitney ' U "
test showed a significant reduction in the
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ascorbyl radical concentration in the
tumour-bearing rats (P < 0.05).
The ascorbyl radical concentration of
the blood of MDMS-treated rats bearing a
Yoshida tumour appeared to be slightly
increased over the controls, but this
increase was not significant (P > 0.05).
Spleen
The spleen weight gradually increased
by approximately 60%, and the concen-
tration of the ascorbyl radical gradually
decreased by approximately 30,0, over
the 14-day period after transplantation.
Yoshida tarmour
The changes in tumour weight with
time, both during its development and
afterMDMS treatment, areshown in Fig. 1.
The changes in the ascorbyl radical
concentration in the viable and degenerat-
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FtV--. 2.- Height of the ascorbyl radical signal per g of tissue, relative to the mainganese marker peak, observed in the tumotut d(lring its clevelopmerit. x dlegeneriating tissue; 0 viable tissue, vertical
lines showr the standard error of the experimental points. Dotted line shows the change in tuimouir
weight w!ith the time (luring the (levelopmernt of the disease.
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Fi,. 3. Height of the ascorbyl radical signal, per g of tissue, relative to the manganese marker peak,
observed in the initially viable tissue ofthe tumour with time after treatment with MDMS. Vertical
lines show the standard error of the experimental points. Dotted line shows the changes in the
height ofthe ascorbyl radical signal, relative to the manganese marker signal, observed in the viable
tissue of an untreated developing tumour. Arrow indicates the day of injection with MDMS.
ing tissues of a developing Yoshida tumour
are shown in Fig. 2. There was an initial
rapid rise in radical concentration in both
tissues after implantation, followed by a
fall to the initial level or below on Days
3-4. A second rise, to a maximum on
about Days 7-8, followed by a decline,
was observed in both tissues.
After treatment with MDMS, the
tumour regressed. The previously viable
tissue became paler in colour and more
necrotic. The ascorbyl radical concen-
tration of this tissue remained relatively
constant for about 2 days after treatment
with MDMS, and then rapidly increased
(Fig. 3). The degenerating tissue became
slightly yellow with time after treatment
with MDMS, but the radical concentration
ofthis tissue was similar in the treated and
untreated tumours (Fig. 4).
Muscle tissue
The ascorbyl radical is not readily
detectable in normal muscle tissue. How-
ever, a signal due to this radical was
clearly visible in a muscle implant 31 h
after implantation. At this stage, a
minor inflammatory response was ob-
served histologically in the implant. The
radical concentration possibly increased
with time, but did not appear to be pro-
portional to the amount of invasion by
normal white cells into the implant.
DISCUSSION
The changes in the ascorbyl radical
concentration are comparable to the
changes in overall radical concentration
observedbyotherauthorsusinglyophilized
tissue (Saprin et al., 1967a, b; Driscoll
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FIG. 4. Height of the ascorbyl radical signal, per g of tissue, relative to the manganese marker signal,
observed in the degenerating tissue ofthe tumour, with time after treatment with MDMS. Vertical
lines show the standard error of the experimental points. Dotted line shows the changes in the
height of the ascorbyl radical signal, relative to the manganese marker signal, observed in the (le-
generating tissue of an untreated developing tumour. Arrow indicates the day of injection with
MDMS.
et al., 1967; Wallace et al., 1970). The
signal in lyophilized tissue has been
related to the presence of ascorbic acid
(Heckly, 1972; Naktinis and Cerniaus-
kiene, 1974). In a wet system the
ascorbyl radical is short-lived (Piette,
Yamazaki and Mason, 1961) and so the
signal in fresh tissue must be due to a
steady state concentration. This is not
directly related tothe ascorbic acid content
of the tissue (Dodd, 1973).
In the developing Yoshida tumour, a
larger signal was seen in the degenerating
tissue regions than in the viable tissue.
Also, aftertreatmentwithMDMS,thesignal
intensity of the initially viable regions
increased as they became more necrotic.
These results imply that the signal does
not reflect a growth requirement of the
cells, but is in some way related to dying
tissue, although experiments to produce
necrosis in vitro and in vivo failed to
produce the ascorbyl radical (Dodd, 1973;
Giron-Conland, 1975).
The results of the experiments with
implanted muscle tissue suggest that the
appearance ofthe signal may be related to
a host-implant reaction. A similar sug-
gestion has been made previously in the
case of an increased ascorbyl radical con-
centration in the spleens of mice carrying
a myeloid leukaemia (Dodd and Giron-
Conland, 1975). Histologicalexamination
of the Yoshida tumour showed that
inflammatory reactions were taking place.
These or other host-tumour reactions may
be involved in the production of the
radical, possibly via cell lysis. The in-
crease in the concentration ofthe ascorbyl
radical after MDMS treatment could be
due to the increased effectiveness of the
host-tumour reaction after some of the
tumour has been destroyed by the cyto-
toxic action of the drug.
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The production of an immune response
by the host against this tumour has been
suggested previously (Fox and Gregory,
1972). The pattern of change in the
concentration ofthe ascorbyl radical ofthe
tumour, both during its development and
regression, is similar to that expected of
IgM antibodies. The putative relation-
ship between the ascorbyl radical and
immune reactions or inflammation is being
further investigated using immunological
techniques and ESR examination of tum-
ours of known antigenicity, grafts and
implants of normal tissue.
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